Ryan Kuehnle, M.D.
@RKuehnleRadOnc
Followers
81
Following
98
Media
4
Statuses
16
Chief Transitional Intern @JPS_Health | Incoming Radiation Oncology Resident @UTSW_RadOnc | #GigEm 👍 | Passionate about humanism in cancer care | Views = mine
Fort Worth, TX
Joined September 2024
With residency on the horizon, ✨ Ryan Kuehnle✨, @TheLongSOM #Classof2025, is ready to learn from some of the best minds in cancer care. Congratulations, Dr. Kuehnle!🤗🧡 #makelivesbetter #countdowntograduation
1
2
7
I wouldn’t be in this position without exceptional mentorship. Thank you @nbn426 for truly exemplifying what it means to go the extra mile for your patients!
3
2
26
This Texas guy is extremely humbled to have the opportunity to serve cancer patients in his home state! 🤠 @UTSW_RadOnc #Match2025
16
1
97
We're thrilled to have each of you join our department! Looking forward to your growth, contributions, and impact on patient care.
0
4
48
No feeling as sweet as to send your mentees and future colleagues out into the world ! So proud of Stockton Rock @OhioStateRadOnc , Colleen conger @NorthwesternU rad onc, Francisco Neal @EmoryRadOncRes , Ryan Kuehnle @UTSW_RadOnc
5
3
80
Compared to TACE, EBRT improves local control and progression free survival but not overall survival in early/intermediate HCC. Larger RCTs are needed to assess outcomes in advanced disease. https://t.co/paDxAjXe81
@RKuehnleRadOnc @nbn426 @freddyeescorcia @OncoAlert
0
6
19
Congrats to @nbn426 and @ryankuehlne in leading this analysis. @NCCN and @BCLC should include this evidence in their next guidelines. #HCC @UTHealthHospMed @UnivTransplant @UTHealthSAMDA @UTHealthSA
Meta‐analysis of randomized controlled trials of external‐beam radiation versus TACE for HCC Pooled analysis of 3 RCTs 💥Compared with TACE, EBRT yields superior local control and PFS early and intermediate stage HCC https://t.co/DPFJPvoTxq
1
7
26
Huge thank you to all of our co-authors for their help on the study! @LeilaTchelebi @ebludmir @freddyeescorcia @NiuSanford @ColinCourtMD @jryckman3 @DrSukeshiArora @EricLehrer @KrishanJethwa
2
2
12
Patients can benefit from SBRT / PBT over TACE in HCC (ineligible for upfront surgery/transplant) ! 🚨 Local Control HR 0.16 (0.08, 0.34) 🚨 💥 PFS HR 0.37 (0.23, 0.60) 💥 OS RR 0.79 (0.51, 1.22) Toxicity RR 0.86 (0.31, 2.37)
1
10
30
Our meta-analysis comparing EBRT & TACE for HCC is here in @JournalCancer ! (Spoiler: RT benefits patients in LC and PFS) Thank you so much @nbn426 for being such an incredible mentor and guiding me every step of the way on the project! https://t.co/0kCQB4cA0x
acsjournals.onlinelibrary.wiley.com
After performing a systematic review and meta-analysis of randomized controlled trials, the authors observed that external-beam radiation therapy produced superior local control and progression-free...
5
23
64
Meta‐analysis of randomized controlled trials of external‐beam radiation versus TACE for HCC Pooled analysis of 3 RCTs 💥Compared with TACE, EBRT yields superior local control and PFS early and intermediate stage HCC https://t.co/DPFJPvoTxq
3
55
131
@5_utr Fantastic! Here is the HR for SBRT vs. TACE in our work. EBRT was associated with improved PFS over TACE (HR: 0.37, 95% CI = 0.23-0.60; I2 = 0%). Here is the abstract from #ASTRO24, the full publication was just accepted in Cancer today!
redjournal.org
Transarterial chemoembolization (TACE) is an option for downstaging or definitive therapy in Hepatocellular Carcinoma (HCC) according to the Barcelona Liver Classification (BCLC) guidelines. However,...
3
13
52
Having a great time at my first #ASTRO24 with a poster presentation! Special thanks to @nbn426 for trusting me with this project, and thank you to our coauthors for all the help! Proud to represent @TheLongSOM & @UTHealthSA
0
0
3
Three of our visiting medical students, (left to right) Ryan Kuehnle, Nicholas Pham, and Olivia Trumble, and one of our research associates, @giuliani_luiza (far right), with our Department Chair, Dr. @BobTimmermanMD. Each gave presentations in our department today!
1
5
27